U.S. Markets open in 6 hrs, 35 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,058.64 | 150.25 | 1.52% |
| NASDAQ | 2,150.87 | 24.82 | 1.17% |
| S&P 500 | 1,070.52 | 13.78 | 1.30% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 2.93 09:31 AM EST | |
|---|---|---|
| Day High | 3.0025 11:05 AM EST |
|
| Range | 0.07 |
| Volume | 80,642 | |
|---|---|---|
| 30-Day Avg Vol | 168,000 |
|
| Difference | -52.00% |
| Market Cap | 199.03 M | |
|---|---|---|
| Mkt Cap Chg | 3.31 M |
| Shares Out | 66.34 M | |
|---|---|---|
| % Shrs Traded | 0.12% | |
| 1yr EPS Est | -0.538 |
| 52-Wk Low | 1.81 | |
|---|---|---|
| 52-Wk High | 6.21 |
|
| Range | 4.40 |
| Prev Close | 2.95 2/8/10 | |
|---|---|---|
| Today's Open | 3.00 | |
| Change | 1.69% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 1.19 M |
| Revenue (LFY) | 10.04 M | |
|---|---|---|
| Earnings (LFY) | -70.21 M | |
| Earnings (MRQ) | -11.67 M | |
| Next Earn Est | -0.188 | |
| Next Earnings | 02/15/2010 |
|
| EPS (TTM) | -0.93 | |
| 1yr EPS Growth | 42.77% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -5.00 | |
| PEG Ratio | — | |
| Return on Equity | -183.00 | |
| Beta | 0.40 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Idenix Pharmaceuticals is not suffering from any identity crisis -- it is clear in its focus on identifying treatments for life-threatening viruses. The biopharmaceutical firm is developing orally administered ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.188 2/15/10 | — — |
—
—
|
| Last Quarter | -0.236 9/30/09 | -0.18 9/30/09 |
0.056
Beat
|
| 2 Quarters Ago | -0.25 6/30/09 | -0.28 6/30/09 |
-0.03
Missed
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 3.11 M | 10.05 M |
| Gross Profit | 1.51 M | -45.58 M |
| Operating Income | -12.00 M | -72.71 M |
| Net Income | -11.67 M | -70.21 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts